About the Episode
Liquid biopsy is evolving fast: monitoring minimal residual disease (MRD) after surgery, measuring tumor mutational burden (TMB) for immunotherapy response, multi-cancer screening tests. This episode separates today's clinical practice from tomorrow's possibilities and honestly discusses which approaches remain in research.
The goal: keep the excitement, keep expectations realistic.
#genel #gelecek
Rx-only — prescription screening test. Galleri® is not a diagnostic test. A positive result does not mean a cancer diagnosis; a negative result does not rule out cancer. The test does not replace the routine cancer screenings recommended by your physician. Galleri® does not detect all cancers.